BiotechTube
Home/Neuvivo/John Curnutte, MD, PhD
JC

John Curnutte, MD, PhD

Board Member

Neuvivo

Therapeutic Areas

Amyotrophic Lateral Sclerosis (ALS)Neurodegenerative Diseases

Neuvivo Pipeline

DrugIndicationPhase
NP001Amyotrophic Lateral Sclerosis (ALS)Phase 3

Leadership Team at Neuvivo

MM
Mike McGrath, MD, PhD
Chief Executive Officer, Co-Founder
AA
Ari Azhir, PhD
Co-Founder
VN
Vern Norviel, JD
Co-Founder
RB
Robert Baffi, PhD, MBA
Board Member
View full Neuvivo profile